Corvus Pharmaceuticals, Inc. - CRVS

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$1.089B
QoQ value delta ($000)
+$40.69M (+3.88%)
Implied price effect (QoQ)
+2.19%
Shares
Total shares
72,887,289
QoQ shares delta
+1,186,482 (+1.65%)
Total shares held by funds (by quarter)

Market chart (CRVS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 174 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
ORBIMED ADVISORS LLC 107,045 7,165,006 1.98%
BlackRock, Inc. 106,653 7,138,811 0.0%
STATE STREET CORP 66,842 4,474,091 0.0%
PRICE T ROWE ASSOCIATES INC /MD/ 56,611 3,789,126 0.01%
VANGUARD CAPITAL MANAGEMENT LLC 49,193 3,292,710 0.0%
ADAMS STREET PARTNERS LLC 48,937 3,275,616 11.06%
Vivo Capital, LLC 41,918 2,805,816 3.83%
WELLINGTON MANAGEMENT GROUP LLP 40,810 2,731,632 0.01%
PERCEPTIVE ADVISORS LLC 39,851 2,667,441 0.6%
Deep Track Capital, LP 37,229 2,491,939 0.54%
BRAIDWELL LP 31,766 2,126,298 1.18%
GEODE CAPITAL MANAGEMENT, LLC 27,700 1,853,659 0.0%
Foresite Capital Management VI LLC 27,358 1,831,233 4.26%
GOLDMAN SACHS GROUP INC 23,550 1,576,352 0.0%
Hood River Capital Management LLC 23,482 1,571,805 0.17%
MORGAN STANLEY 20,090 1,344,736 0.0%
Boxer Capital Management, LLC 16,434 1,100,000 1.24%
Catalio Capital Management, LP 16,148 1,080,888 3.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,689 1,050,141 0.0%
MILLENNIUM MANAGEMENT LLC 15,656 1,047,985 0.01%
CITADEL ADVISORS LLC 15,580 1,042,851 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 12,172 814,750 0.0%
TWO SIGMA INVESTMENTS, LP 11,731 785,208 0.01%
BANK OF AMERICA CORP /DE/ 11,321 757,798 0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11,205 750,000 0.02%